Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.03 - $5.32 $1.69 Million - $2.96 Million
-556,281 Reduced 43.52%
721,824 $2.63 Million
Q1 2022

May 16, 2022

BUY
$4.66 - $7.66 $3.38 Million - $5.56 Million
725,324 Added 131.21%
1,278,105 $6.51 Million
Q4 2021

Feb 14, 2022

SELL
$6.82 - $17.8 $5.04 Million - $13.2 Million
-739,091 Reduced 57.21%
552,781 $4.22 Million
Q3 2021

Nov 15, 2021

SELL
$13.62 - $19.48 $1.09 Million - $1.56 Million
-79,952 Reduced 5.83%
1,291,872 $18 Million
Q2 2021

Aug 16, 2021

BUY
$16.94 - $19.89 $23.2 Million - $27.3 Million
1,371,824 New
1,371,824 $23.2 Million

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.